| Dr Nicole Cornish, DNP, APRN-C | |
|
3400 S Douglas Blvd, Suite 305, Oklahoma City, OK 73150-1001 | |
| (405) 622-3063 | |
| (405) 732-0022 |
| Full Name | Dr Nicole Cornish |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Primary Care |
| Location | 3400 S Douglas Blvd, Oklahoma City, Oklahoma |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003296492 | NPI | - | NPPES |
| Entity Name | Holloway Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497848147 PECOS PAC ID: 1951297985 Enrollment ID: O20040225001056 |
News Archive
Conventional wisdom has it that volunteering is good for you, and a study at Hospital for Special Surgery shows that to be true for people with lupus volunteering in a peer support and education program.
Gilead Sciences, Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for the Quad, a complete single-tablet HIV regimen containing elvitegravir, cobicistat, emtricitabine and tenofovir disoproxil fumarate.
A new study published in the journal Nature Medicine on January 2020 suggests that Parkinson's disease developing before the age of 50 years could be due to an abnormality in certain brain cells that remains dormant until the age of onset of the disease. It also indicates the potential usefulness of a specific drug to prevent this by correcting the brain cell disorder.
The turning point for people with COVID-19 typically comes in the second week of symptoms. As most people begin to recover, a few others find it increasingly difficult to breathe and wind up in the hospital.
› Verified 1 days ago
| Entity Name | Oklahoma Mental Health Council |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275574907 PECOS PAC ID: 3173514387 Enrollment ID: O20040518001034 |
News Archive
Conventional wisdom has it that volunteering is good for you, and a study at Hospital for Special Surgery shows that to be true for people with lupus volunteering in a peer support and education program.
Gilead Sciences, Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for the Quad, a complete single-tablet HIV regimen containing elvitegravir, cobicistat, emtricitabine and tenofovir disoproxil fumarate.
A new study published in the journal Nature Medicine on January 2020 suggests that Parkinson's disease developing before the age of 50 years could be due to an abnormality in certain brain cells that remains dormant until the age of onset of the disease. It also indicates the potential usefulness of a specific drug to prevent this by correcting the brain cell disorder.
The turning point for people with COVID-19 typically comes in the second week of symptoms. As most people begin to recover, a few others find it increasingly difficult to breathe and wind up in the hospital.
› Verified 1 days ago
| Entity Name | Questcare Hospitalists Oklahoma Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578909388 PECOS PAC ID: 6901049022 Enrollment ID: O20130821000297 |
News Archive
Conventional wisdom has it that volunteering is good for you, and a study at Hospital for Special Surgery shows that to be true for people with lupus volunteering in a peer support and education program.
Gilead Sciences, Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for the Quad, a complete single-tablet HIV regimen containing elvitegravir, cobicistat, emtricitabine and tenofovir disoproxil fumarate.
A new study published in the journal Nature Medicine on January 2020 suggests that Parkinson's disease developing before the age of 50 years could be due to an abnormality in certain brain cells that remains dormant until the age of onset of the disease. It also indicates the potential usefulness of a specific drug to prevent this by correcting the brain cell disorder.
The turning point for people with COVID-19 typically comes in the second week of symptoms. As most people begin to recover, a few others find it increasingly difficult to breathe and wind up in the hospital.
› Verified 1 days ago
| Entity Name | Forefront-rush Medical Service Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083036651 PECOS PAC ID: 4486884285 Enrollment ID: O20170608002204 |
News Archive
Conventional wisdom has it that volunteering is good for you, and a study at Hospital for Special Surgery shows that to be true for people with lupus volunteering in a peer support and education program.
Gilead Sciences, Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for the Quad, a complete single-tablet HIV regimen containing elvitegravir, cobicistat, emtricitabine and tenofovir disoproxil fumarate.
A new study published in the journal Nature Medicine on January 2020 suggests that Parkinson's disease developing before the age of 50 years could be due to an abnormality in certain brain cells that remains dormant until the age of onset of the disease. It also indicates the potential usefulness of a specific drug to prevent this by correcting the brain cell disorder.
The turning point for people with COVID-19 typically comes in the second week of symptoms. As most people begin to recover, a few others find it increasingly difficult to breathe and wind up in the hospital.
› Verified 1 days ago
| Entity Name | Previse Medical Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699433961 PECOS PAC ID: 4385036748 Enrollment ID: O20220114000109 |
News Archive
Conventional wisdom has it that volunteering is good for you, and a study at Hospital for Special Surgery shows that to be true for people with lupus volunteering in a peer support and education program.
Gilead Sciences, Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for the Quad, a complete single-tablet HIV regimen containing elvitegravir, cobicistat, emtricitabine and tenofovir disoproxil fumarate.
A new study published in the journal Nature Medicine on January 2020 suggests that Parkinson's disease developing before the age of 50 years could be due to an abnormality in certain brain cells that remains dormant until the age of onset of the disease. It also indicates the potential usefulness of a specific drug to prevent this by correcting the brain cell disorder.
The turning point for people with COVID-19 typically comes in the second week of symptoms. As most people begin to recover, a few others find it increasingly difficult to breathe and wind up in the hospital.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Nicole Cornish, DNP, APRN-C 3400 S Douglas Blvd, Suite 305, Oklahoma City, OK 73150-1001 Ph: (405) 622-3063 | Dr Nicole Cornish, DNP, APRN-C 3400 S Douglas Blvd, Suite 305, Oklahoma City, OK 73150-1001 Ph: (405) 622-3063 |
News Archive
Conventional wisdom has it that volunteering is good for you, and a study at Hospital for Special Surgery shows that to be true for people with lupus volunteering in a peer support and education program.
Gilead Sciences, Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for the Quad, a complete single-tablet HIV regimen containing elvitegravir, cobicistat, emtricitabine and tenofovir disoproxil fumarate.
A new study published in the journal Nature Medicine on January 2020 suggests that Parkinson's disease developing before the age of 50 years could be due to an abnormality in certain brain cells that remains dormant until the age of onset of the disease. It also indicates the potential usefulness of a specific drug to prevent this by correcting the brain cell disorder.
The turning point for people with COVID-19 typically comes in the second week of symptoms. As most people begin to recover, a few others find it increasingly difficult to breathe and wind up in the hospital.
› Verified 1 days ago
Ann R Benson, BSN, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1000 Ne 10th St, Oklahoma City, OK 73117 Phone: 405-271-4476 Fax: 405-271-9202 | |
Mrs. Judy Kay Kellogg, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1025 Straka Ter, Oklahoma City, OK 73139 Phone: 405-632-6688 Fax: 405-604-0708 | |
Mrs. Darbi Lynne Williams, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 4050 W Memorial Rd, Oklahoma City, OK 73120 Phone: 405-608-3800 Fax: 405-608-3838 | |
Tammy Ann Harrelson, APRN-CNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 14000 N Portland Ave, Suite 201, Oklahoma City, OK 73134 Phone: 405-606-2727 Fax: 405-606-7040 | |
Liji Seilas, ARNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1901 Springlake Dr, Oklahoma City, OK 73111 Phone: 405-521-8486 Fax: 405-521-8496 | |
Hilary Lauren Knippers, APRN-CNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 3110sw89th St 200d, Oklahoma City, OK 73159 Phone: 405-680-5633 Fax: 405-799-7400 | |
Mrs. Rachel Leigh Cross, APRN, CPNP-PC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1200 Childrens Ave, Suite 10000, Oklahoma City, OK 73104 Phone: 405-271-4412 |